Application Type
Patent
Application SubType
PCT National Phase
(10) Registration Number and Date
BNN20180043 10.11.2022
Status
Registered
(180) Expiration Date
(20) Filing Number and Date
BN N/2018/0043 08.11.2016
(40) Publication Number and Date
BN N/2018/0043
A
10.11.2022
(86) PCT Filing Number and Date
(87) PCT Publication Number and Date
(85) National Entry Date
(30) Priority Details
US 62/401,351
29.09.2016
US 62/252,726
09.11.2015
(51) IPC Classes
(74) Representative Name
(54) Title
(EN) DIHYDROIMIDAZOPYRAZINONE DERIVATIVES USEFUL IN THE TREATMENT OF CANCER
(57) Abstract
(EN)

The present disclosure concerns compounds of Formula (I) or pharmaceutically-acceptable salts thereof, wherein R1, R2 and R3 have any of the meanings defined hereinbefore in the description; processes for their preparation, pharmaceutical compositions containing them and their use in the treatment of cancer.

(58) Citations
Document Type Date Action
Event NameDateStatus
Filing08.11.2016Filed
PCT National Phase Entry07.05.2018PCT National Phase
Registration10.11.2022Registered
Publication10.11.2022Published